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Do baseline characteristics predict response to treatment for
low back pain? Secondary analysis of the UK BEAM dataset
[ISRCTN32683578]
M. R. Underwood1, V. Morton2 and A. Farrin3 on behalf of the UK BEAM trial team2,4
Objectives. To identify characteristics of randomized controlled trial participants which predict greater benefits from physical treatments for
low back pain. If successful, this would allow more appropriate selection of patients for different treatments.
Methods.We did a secondary analysis of the UK Back pain Exercise And Manipulation trial (UK BEAM n¼ 1334) dataset to identify baseline
characteristics predicting response to manipulation, exercise and manipulation followed by exercise (combined treatment). Rather than
simply identifying factors associated with overall outcome, we tested for the statistical significance of the interaction between treatment
allocation, baseline characteristics and outcome to identify factors that predicted response to treatment. We also did a post-hoc subgroup
analysis to present separate results for trial participants with subacute and chronic low back pain to inform future evidence synthesis.
Results. Age, work status, age of leaving school, ‘pain and disability’, ‘quality of life’ and ‘beliefs’ at baseline all predicted overall outcome.
None of these predicted response to treatment. In those allocated to combined treatment, there was a suggestion that expecting treatment to
be helpful might improve outcome at 1 yr. Episode length at study entry did not predict response to treatment.
Conclusion. Baseline participant characteristics did not predict response to the UK BEAM treatment packages. Using recognized prognostic
variables to select patients for different treatment packages, without first demonstrating that these factors affect response to treatment, may
be inappropriate. In particular, this analysis suggests that the distinction between subacute and chronic low back pain may not be useful when
considering treatment choices.
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Introduction
Low back pain has a major health and social impact [1]. There are
now many randomized controlled trials of different treatment
approaches for low back pain. However, these rarely show more
than a small to moderate overall benefit from the treatment [2].
The need to identify which subgroups of back pain patients are
likely to gain the most from different interventions is well
recognized [3]. There is substantial literature on the predictors
of poor outcome from low back pain. Only a few studies have
considered, within randomized controlled trials, which patient
factors identify those who are most likely to gain the greatest
benefit from the treatments tested.
Karjalainen [4] found that a brief intervention was most
effective in those who perceived that they had greatest risk of not
recovering. Hagen [5] found that the benefit of attending a spine
clinic was greatest in those with a low-health locus of control
at 3 months and at 1 yr; and in those with constant pain at
3 months but not at 1 yr. Hagen also found that presence of
gastro-intestinal complaints predicted who was most likely
to respond to treatment. Both Karjalainen and Hagen looked
for an interaction between baseline characteristics and treatment
group in a multivariate model to identify possible modifiers of
treatment effect.
In post-hoc subgroup analyses of randomized controlled trials,
Burton [6] found that an educational booklet had had a
beneficial effect only in those with high fear-avoidance scores;
and Klaber Moffett [7] found that those with high fear avoidance
benefited most from an exercise programme. George et al. [8]
found that patients with high initial fear-avoidance beliefs
benefited more from fear-avoidance-based physiotherapy than
those with low fear-avoidance beliefs. Childs et al. [9, 10] in a
randomized controlled trial of exercise compared with exercise
plus manipulation, used a clinical prediction rule (presence of four
of the following: short symptom duration, fear-avoidance beliefs,
lumbar hypomobility, hip internal rotation range of motion
and no symptoms distal to the knee) that identified those with
a good prognosis and found that those allocated to manipulation,
who were positive on the prediction rule, gained the greatest
benefit.
We have completed a large, primary care-based, randomized
controlled trial of physical treatments for back pain: the UK Back
pain Exercise And Manipulation trial (UK BEAM) [11–13].
Our principal findings were that when compared with ‘best care’
in general practice [14, 15], a package of spinal manipulation [16]
produced a small to moderate benefit at 3 months and a small
benefit at 1 yr; that a programme of exercise [17] produced a small
benefit at 3 months, but not 12 months; and that manipulation
followed by exercise (combined treatment) produced a moderate
benefit at 3 months and a small benefit at 1 yr.
Our primary outcome measure was the Roland Morris
Disability Questionnaire (RMDQ) [18]. The largest additional
benefit from adding physical treatments to ‘best care’ in general
practice was 1.87 [95% confidence interval (CI) 1.15–2.60] RMDQ
points, for combined treatment at 3 months following randomiza-
tion. For our sample size calculation, we set the clinically
important difference at 2.5 (S.D. 4.0) RMDQ points [13]. The
mean benefit we observed is unlikely to be important for an
individual patient [19].
UK BEAM included participants with ‘simple low back pain’
lasting at least 4 weeks and randomized them to four different
treatment packages. Within each of these packages, the individual
general practitioner or therapist had considerable freedom to
decide how he/she treated individual patients. The diagnosis of
simple low back pain reflects our inability to identify meaningful
definitions of different back pain subgroups [3]. Thus UK BEAM
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recruited a heterogeneous group of patients with low back pain.
Nevertheless, we observed statistically significant benefits from
our additional treatment packages. Some participants gained an
important benefit from some of the additional treatments; for
some participants they were ineffective; and some participants
might have been made worse. Qualitative analysis of participants’
comments supports the notion that some gained substantial
benefits from the intervention packages [20]. Identifying which
patients are more likely to benefit from these treatment packages
would allow more efficient targeting of resources.
Duration of the pain episode is commonly used to inform
the management of low back pain. Current guidelines for
the management of back pain generally consider acute/subacute
(<3 months) and chronic (>3 months) pain separately. Our
primary analysis, which pooled patients with both subacute and
chronic pain, does not allow our results directly to inform
guideline development because meta-analysts and guideline
developers typically exclude trials including a mixture of
participants with a long and short duration of low back pain.
The main results from UK BEAM led us to hypothesize
that, as well as duration, other baseline characteristics could
differentially affect the size of benefits from treatments.
For example, those allocated to exercise, unlike those randomized
to manipulation, demonstrated large changes in fear-avoidance
beliefs. This suggests that people with high fear-avoidance
might gain the greatest benefit from exercise and those with low
fear-avoidance the greatest benefit from manipulation.
In summary, little is known about the relationships between
patient characteristics and response to specific low back pain
treatments. If identifiable individual patient factors predict
treatment response, back pain treatment could be substantially
improved by targeting interventions at those likely to gain the
greatest benefit. We have conducted further analyses of the
UK BEAM data to assess the impact of participant baseline
characteristics on response to treatment and to present appro-
priate data to inform future meta-analyses and guideline
development.
Methods
UK BEAM is reported in detail elsewhere [11–13]. We briefly
summarize the method here.
Participant recruitment and follow-up
We recruited 1334 participants from 181 general practices from
the Medical Research Council General Practice Research
Framework (www.gprf-mrc.ac.uk) in 14 clusters across the UK.
Participants were patients aged 18–64 who had consulted these
practices with simple low back pain that failed to resolve after
their consultation. All participants’ current episode of back pain
had lasted for at least 4 weeks. Before randomization, research
nurses based in each practice collected routine demographic data
and participants completed a baseline assessment questionnaire.
Follow-up was by postal questionnaire 3 months and 1 yr after
randomization. Ethical review was provided by Northern and
Yorkshire Multi-Centre Research Ethics Committee.
Interventions: ‘best care’ in general practice—the
‘control’ treatment
We trained all general practice teams in the ‘active management’
of back pain [14, 15] and they provided patients with copies of
‘The Back Book’ [21].
Exercise programme. This consisted of an initial individual
assessment followed by up to nine group classes over 12 weeks
delivered in community facilities [17].
Spinal manipulation package. The UK chiropractic, osteo-
pathic and physiotherapy professions agreed a package
of techniques developed by a multidisciplinary group [16].
We invited participants to attend up to eight sessions over up to
12 weeks.
Combined treatment. Participants allocated to this group
received up to 6 weeks of manipulation followed by up to 6 weeks
of exercise. Apart from the timing, all aspects of treatment were
identical to those in the manipulation-only or exercise-only
groups.
Randomization
We randomized participants between four treatment options—
‘best care in general practice’, ‘best care’ plus spinal manipulation
package, ‘best care’ plus class-based exercise program and ‘best
care’ plus combined treatment.
Baseline data collection
Before randomization, we collected the following baseline data.
Health status. The RMDQ [18], a well-established outcome
measure for community-based back pain studies [22], was our
primary outcome measure. We measured generic health status
using the Short Form 36-item Health Survey (SF-36) [23], and the
EQ5D [24]. We complemented these with measures for back pain
and disability derived from the chronic pain grade (MVK pain
and MVK disability) [25, 26] and single-item questions on
‘troublesomeness’ of low back pain and leg pain anglicized from
previously used ‘bothersomeness’ questions [27]. These questions
were on a 5-point Likert scale, ranging from not at all
troublesome to extremely troublesome. These were converted
into 1–5 numerical values for this analysis.
Back pain beliefs. We measured beliefs about back pain
using the physical sub-scale of the Fear Avoidance Beliefs
Questionnaire physical (FABQ) [28] and the inevitability subscale
of the Back Beliefs Questionnaire (BBQ) [29].
Psychological instruments. We assessed psychological state
using the Distress and Risk Assessment Method (DRAM) which
is derived from Modified Somatic Perception Questionnaire and
Modified Zung Depression Inventory [30].
Treatment expectations. We asked participants before ran-
domization for their expectation for a benefit from each treatment
option using a 3-point Likert scale: how helpful do you think
treatment from (each treatment) will be for your back pain, very
helpful, helpful or not helpful?
Other data. We collected basic demographic data, informa-
tion on educational attainment, work status and duration of
current episode of back pain.
Statistical methods
In our baseline dataset, we had 18 candidate explanatory
variables: 11 health status measures, four demographic measures,
duration of episode, expectation of benefit from treatment and
randomized treatment (Table 1). In an initial exploratory analysis,
we found that our 11 health status measures were highly
correlated with each other. This would cause problems of
multicollinearity in a multiple regression model, making the
results difficult to interpret. To reduce the number of variables
we put into the regression model, we first carried out a
principal component analysis using varimax rotation with
Kaiser normalization to determine a smaller number of uncorre-
lated components that could then be used in the regression
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analyses [31]. Principal component analysis produces a set
of Eigen values and a corresponding Eigen vector; the Eigen
vectors contain weights that can be used to compute the new
variables from the original ones. Each of the new variables is a
combination of the weighted original variables with the weighting
determined by the Eigen vectors for each of the new ‘factors’ [32].
We then carried out initial analyses, using our new variables
(‘Pain and Disability’, ‘Quality of Life’ and ‘Beliefs’), to explore
the extent to which all of our baseline variables predicted overall
outcome at 3 and 12 months, respectively. We did an ordinary
least square regression, with the RMDQ score at 3 or 12 months
as the dependent variable. To test the hypothesis that patient
characteristics could predict response to different treatments,
we analysed our 3- and 12-month outcomes testing for the
interaction between treatment allocation and each of our baseline
variables [33].
This approach makes the best use of the available data and
avoids the problems inherent in doing multiple subgroup analyses
[34, 35]. For these analyses we excluded data from participants
recruited from the 13 pilot study practices, who were included in
our main analyses, because of slight differences in the coding of
the ‘helpfulness’ question in these participants.
Because of the importance ascribed to episode duration in
planning treatment services, we proceeded to carry out a further
analysis looking for an interaction in a model that included
only duration and treatment allocation. This analysis again avoids
problems with post-hoc subgroup analyses. Analysis of covari-
ance, adjusting for baseline RMDQ score, was used to investigate
any potential relationships between treatment allocation and the
binary duration variable (<90 days and 90 days). The variable of
interest was the interaction between the binary duration variable
and treatment allocation.
Notwithstanding our reservations about post-hoc subgroup
analyses, because it is currently common practice to use a defined
cut-off time for episode duration when synthesizing evidence
on the treatment of low back pain, we carried out a post-hoc sub-
group analysis presenting the results for those with <90 days and
90 days separately to inform future evidence synthesis.
Results
Baseline data
We had complete datasets on 1116 participants at baseline that
contributed to this analysis. We identified three factors with an
Eigen Value of >1; ‘Pain and Disability’, ‘Quality of Life’ and
‘Beliefs’. Together these factors explained 64.1% of the variance in
the baseline data: 42.5, 12.7 and 8.9%, respectively (Table 2). We
then used the individual participants’ scores for each factor in the
next stage of the analysis. Participants had high expectations for
success from the different treatment options: 92, 86 and 97%,
respectively, expected manipulation, exercise, or combined treat-
ment to be helpful or very helpful, though only 63% had the same
level of expectation for general practice care.
Overall predictors of outcome
The mean improvement in participants randomized to any of the
active interventions was greater than usual care at 3 months. This
was sustained at 1 yr for manipulation and combined treatment
but not for exercise. Higher levels of education, lower age, shorter
episode length and being at work were all associated with a better
outcome. Higher values in our three new factors, that is more pain
and disability, poorer quality of life and less favourable beliefs,
were all strongly associated with a poorer outcome at both
3 months and 1 yr (Table 3). Our baseline variables predicted
TABLE 3. Multivariate analysis of overall predictors of outcome
Three months (n¼723) One year (n¼ 700)
 P 95% CI  P 95% CI
Manipþexa 1.8 <0.001 (2.8, 0.9) 1.4 0.005 (2.3, 0.4)
Manipulationa 1.3 0.003 (2.2, 0.4) 0.6 0.178 (1.8–0.1)
Exercisea 1.3 0.005 (2.2, 0.4) 0.8 0.178 (1.5–0.3)
Additional educationb 0.7 0.033 (1.3, 0.1) 1.1 0.001 (1.7, 0.4)
Workingc 1.3 0.001 (2.0, 0.5) 1.3 0.001 (2.1, 0.6)
Aged 0.05 0.001 (0.02, –0.08) 0.1 0.002 (0.02, 0.08)
Very helpfule 0.6 0.202 (1.6, –0.4) 0.6 0.272 (1.6, 0.5)
Helpfule 0.1 0.776 (1.0, –0.8) 0.2 0.722 (0.8, 1.1)
Malef 0.7 0.037 (1.3, 0.04) 0.6 0.081 (0.1, 1.2)
Pain and disabilityg 1.7 <0.001 (1.4, 2.0) 2.0 <0.001 (1.7, 2.3)
Quality of lifeh 0.7 <0.001 (0.4, 1.1) 0.8 <0.001 (0.5, 1.1)
Beliefsi 1.2 <0.001 (0.9, 1.5) 1.0 <0.001 (0.7, 1.4)
Episode lengthj 0.4 <0.001 (0.2, 0.6) 0.5 <0.001 (0.3, 0.7)
Parameter estimate for each factor, corrected for all variables in this model. Negative values
indicate more improvement. Outcome¼RMDQ score.
avs ‘best care’.
bvs no additional education after age 16.
cvs not working.
dFor each year age difference.
eAllocated treatment not helpful.
fvs female.
gPain and disability—higher score represents a greater degree of pain and disability (worse).
hQuality of life—a higher score represents poorer quality of life.
iBeliefs—a higher score represents less favourable beliefs.
jSubacute vs chronic.
TABLE 1. Candidate explanatory baseline variables
Health status measures
Roland Morris disability questionnaire [18]
SF-36 mental component score (MCS) [23]
SF-36 physical component score (PCS) [23]
EQ-5D [24]
Modified Von Korff—disability [25, 26]
Modified Von Korff—pain [25, 26]
Troublesomeness questions—low back pain [27]
Troublesomeness questions—leg pain [27]
Fear avoidance beliefs questionnaire physical subscale [28]
Back beliefs questionnaire [29]





Age of leaving full-time education
Working/not working
Duration
Length of current episode in days
Expectation for helpfulness
Response to pre-randomisation question of whether they thought their eventual
treatment allocation would be helpful
Treatment allocation
TABLE 2. Rotated component matrix baseline data (N¼ 1158)
Pain and disability Quality of life Beliefs
RMDQ 0.580 0.219 0.398
SF-36 MCS score (T-score) 0.895 0.111
SF-36 PCS score (T-score) 0.730 0.148 0.395
EQ 5D 0.615 0.347 0.226
Modified Von Korff—pain 0.743 0.244 0.234
Modified Von Korff—disability 0.652 0.251 0.408
Troublesomeness—low back pain 0.744 0.186
Troublesomeness—leg pain 0.630 0.148 0.125
FABQ physical—baseline 0.117 0.836
BBQ baseline 0.167 0.284 0.710
MSPQ 0.261 0.725
Modified Zung 0.247 0.827 0.203
Extraction method: principal component analysis. Rotation method: varimax with Kaiser
Normalization. Rotation converged in five iterations.
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32.7 and 33.2% of the variance in outcome at 3 months and 1 yr,
respectively (adjusted R2).
Interaction between baseline variables and
treatment response
The only interactions that approached statistical significance were:
(i) between combined treatment and expectation that the
treatment would be helpful at baseline and the 1-yr RMDQ
score [4.0 RMDQ points (P¼ 0.019, 95% CI 7.4, 0.7)];
(ii) between combined treatment and expectation that the
treatment would be very helpful at baseline and the 1-yr RMDQ
score [3.8 RMDQ points (P¼ 0.038, 95% CI 7.4, 0.2)]
(Table 4).
These results suggest that participants allocated to combined
treatment who expected this treatment to be helpful or very
helpful respectively gain an additional 4.0 and 3.8 points
improvement in the RMDQ at 1 yr when compared with those
who did not think the treatment would be helpful. These
apparently statistically significant results may be chance findings
because of the large number of comparisons.
Effect of duration at baseline
There were no statistically significant interactions between
episode length as a continuous variable or as a categorical
variable (<90 days vs 90 days) with outcome at either 3 months
or 1 yr. The benefits from treatment for the three active
interventions for subgroups with subacute and chronic pain are
presented in Table 5.
Discussion
Although a number of our baseline measures, age, work status,
age of leaving school, ‘pain and disability’, ‘quality of life’ and
‘beliefs’ at baseline, predicted overall outcome, none of these
predicted response to treatment. There was a suggestion that
expecting treatment to be helpful might improve outcome at 1 yr
in those allocated to combined treatment. The duration of the
current episode of back pain did not predict whether participants
benefited from the treatment packages.
TABLE 4. Interaction between significant baseline variables and treatment allocation
Month 3 Month 12
 P 95% CI  P 95% CI
Combined Episode length 0.3 0.302 (0.80, 0.25) 0.0 0.950 (0.56, 0.53)
Combined Beliefs 0.1 0.905 (0.90, 0.80) 0.3 0.474 (1.20, 0.56)
Combined Quality of life 0.6 0.174 (0.26, 1.43) 0.5 0.252 (0.36, 1.38)
Combined Pain/disability 0.2 0.745 (0.73, 1.02) 0.2 0.703 (0.72, 1.07)
Combined Gender 0.3 0.736 (1.41, 2.00) 0.4 0.639 (2.19, 1.34)
Combined Treatment, helpful 3.2 0.073 (6.74, 0.30) 3.8 0.038 (7.39, 0.20)*
Combined Treatment, very helpful 2.2 0.192 (5.49, 1.11) 4.0 0.019 (7.38, 0.67)*
Combined Age 0.0 0.734 (0.09, 0.07) 0.0 0.429 (0.113, 0.048)
Combined Work 0.2 0.813 (2.22, 1.74) 0.6 0.548 (2.67, 1.42)
Combined Education 0.0 0.963 (1.78, 1.69) 0.8 0.411 (1.04, 2.54)
Exercise Episode length 0.1 0.840 (0.96, 0.78) 0.0 0.998 (0.88, 0.88)
Exercise Beliefs 0.1 0.793 (0.99, 0.76) 0.3 0.582 (0.66, 1.18)
Exercise Quality of life 0.2 0.706 (1.04, 0.71) 0.0 0.997 (0.90, 0.91)
Exercise Pain/disability 0.2 0.816 (1.55, 1.97) 1.0 0.312 (2.80, 0.90)
Exercise Gender 1.2 0.384 (3.96, 1.53) 1.3 0.400 (4.17, 1.67)
Exercise Treatment, helpful 0.4 0.724 (1.92, 2.75) 0.1 0.924 (2.57, 2.33)
Exercise Treatment, very helpful 0.0 0.781 (0.07, 0.10) 0.0 0.427 (0.13, 0.05)
Exercise Age 0.7 0.513 (1.39, 2.78) 0.9 0.403 (3.05, 1.23)
Exercise Work 1.0 0.295 (0.83, 2.72) 0.7 0.473 (1.18, 2.54)
Exercise Education 0.3 0.347 (0.76, 0.27) 0.2 0.546 (0.71, 0.37)
Manipulation Episode length 0.2 0.729 (1.01, 0.71) 0.1 0.801 (0.78, 1.00)
Manipulation Beliefs 0.8 0.070 (1.62, 0.06) 0.4 0.328 (1.29, 0.43)
Manipulation Quality of life 1.4 0.118 (0.35, 3.07) 0.5 0.583 (1.28, 2.28)
Manipulation Pain/disability 1.9 0.176 (4.61, 0.85) 2.2 0.143 (5.16, 0.75)
Manipulation Gender 0.3 0.788 (2.06, 2.71) 0.4 0.774 (2.23, 3.00)
Manipulation Treatment, helpful 0.0 0.669 (0.10, 0.06) 0.1 0.083 (0.16, 0.01)
Manipulation Treatment, very helpful 1.6 0.113 (0.38, 3.60) 1.2 0.250 (0.86, 3.29)
Manipulation Age 0.2 0.806 (1.49, 1.91) 1.1 0.218 (0.66, 2.90)
Manipulation Work 0.3 0.302 (0.80, 0.25) 0.0 0.950 (0.56, 0.53)
Manipulation Education 0.1 0.905 (0.90, 0.80) 0.3 0.474 (1.20, 0.56)
Parameter estimate for each factor, corrected for all variables in this model. Negative values represent a lower score at follow-up point (better outcome). Outcome¼RMDQ score. *p<0.05
TABLE 5. Additional benefit in RMDQ from adding treatment packages to ‘best care’
Three months One year
n Difference P 95% CI n Difference P 95% CI
Chronic n¼878
‘Best care’ 165 – – – 157 – – –
Combined 172 1.39 0.043 (2.74, 0.04) 172 1.52 0.04 (2.96, 0.09)
Manipulation 183 0.91 0.159 (2.18, 0.36) 175 0.55 0.44 (1.92, 0.83)
Exercise 147 1.24 0.072 (2.59, 0.11) 142 1.33 0.08 (2.79, 0.14)
Sub-acute n¼393
‘Best Care’ 80 – – – 81 – – –
Combined 71 2.06 <0.001 (2.96, 1.16) 70 1.15 0.02 (2.12, 0.18)
Manipulation 90 1.69 <0.001 (2.57, 0.80) 83 1.24 0.01 (2.21, 0.27)
Exercise 70 1.23 0.010 (2.17, 0.29) 65 0.23 0.66 (0.79, 1.25)
Sixty-three participants did not have duration recorded.
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Identifying subgroups
As with all secondary analyses, our findings need to be interpreted
with caution. Some of the treatment-effect sizes in this analysis are
slightly different from those in the main UK BEAM analysis
because of the use of different baseline covariates. The main UK
BEAM clinical outcomes paper remains the definitive analysis of
the treatment effects. UK BEAM is an unusual randomized
controlled trial of back pain because it is of sufficient size to
enable us to analyse baseline factors that might predict response to
treatment. However, UK BEAM was not designed to identify
these predictors, so it is possible that we still had insufficient
statistical power to identify such clinically important interactions
if they did exist [35].
Our initial factor analysis developed three independent factors
from the baseline variables, which equate to broad domains that
would be widely accepted as predicting outcome for patients with
low back pain (‘Pain and Disability’, ‘Quality of Life’ and
‘Beliefs’). They all have highly significant associations with
outcome, suggesting that they are appropriate factors to use in
these analyses. We were not able to derive our new factors in a
different dataset than that used for the final analysis; the dataset
was not large enough to allow us to derive our factors in one half
and test them in the other half. This may lead to us overestimating
the importance of these factors. There are inherent weaknesses in
pooling multiple outcome instruments that are measuring
different constructs. However, only by doing this were we able
to test whether these broad factors of ‘pain and disability’, ‘quality
of life’ and ‘beliefs’, which resonate for individual clinicians,
do have an impact on treatment response.
This article is not focused on identifying overall predictors of
outcome for patients with back pain. Nevertheless, it is reassuring
that the independent predictors of outcome broadly concur with
those found in epidemiological studies. It is disappointing that we
were unable to identify any convincing predictors of response to
treatment.
Only for expectations of treatment helpfulness in those
allocated to combined treatment was there a significant interac-
tion between allocation and response to treatment. In view of the
large number of comparisons made, we cannot conclude that these
findings can be used to inform treatment choices.
Our baseline measures together explained only 33% of the
variance in outcome. Although there are statistically strong
associations between our baseline measures and final outcome,
two-thirds of what predicts outcome has not been captured
by them.
Simply presenting the statistical significance of an association
between baseline data and outcome may be misleading as it does
not show the actual strength of the association, nor does it equate
to positive and negative predictive values. Since we can explain
only a small proportion of the overall variance, it is not surprising
that even in the large UK BEAM dataset we were unable to
predict response to treatment.
This is in marked contrast to other, much smaller studies which,
using subgroup analyses, have reported effect sizes for an
additional treatment benefit of a similar magnitude to our main
treatment effects using different baseline measures [6, 7, 9, 10].
However, it should be noted that both study populations and
baseline measures collected differed between these studies and UK
BEAM. For example, Childs’ clinical prediction rule includes
duration of <16 days and results of a physical examination [9].
In contrast, UK BEAM only included people with continuing
back pain at least 4 weeks after an initial consultation and did not
include a physical examination.
Our analyses suggest that it is inappropriate to use overall
predictors of outcome to inform specific treatment choices
without first demonstrating that these do indeed predict response
to treatment. More encouragingly both Karjalainen and
Hagen [4, 5], using a similar statistical approach to the one we
have used here, albeit in different populations and using different
baseline measures, have found possible, easily assessed predictors
of response to specific treatments. Furthermore, Brennan et al.
[36] found that selecting different physical therapy approaches to
match participants’ baseline characteristics appears to improve
outcome. However, a no-treatment or usual-care arm was
not included in this study. Further trials that are powered to
show the interaction between pre-specified baseline characteristics
and treatment outcome, with a usual care control group, are
a possibility. Based on current work it would be possible to
identify some factors that could be used in such studies. However,
such trials are likely to be expensive and time-consuming. For
example, the sample size estimate needs to be increased 4-fold to
show an interaction of a similar magnitude to the main effect
sought [35].
Effect of episode duration
Notwithstanding our reservations about subgroup analyses,
there is some utility in considering the distinction between
subacute and chronic pain. Contrary to our expectations, episode
duration did not predict a differential response to different
treatments for patients with subacute or chronic back pain.
This study does not allow us to comment on any differential
treatment effects for those with acute back pain. Current
orthodoxy, endorsed by numerous national and international
guidelines, is to consider acute and chronic back pain separately
when planning treatment recommendations. Some have chal-
lenged this, positing that almost all back pain is a ‘chronic
problem with an untidy pattern of grumbling symptoms’ [37].
Nevertheless, the distinction between acute and chronic low
back pain would have utility if it allowed us to target treatment
resources more effectively. Our findings do not support the notion
that those with less persistent pain gain a greater benefit from
treatment; rather, these physical treatments should be equally
accessible to all patients with sub-acute or chronic low back.
Our findings support the view that splitting back pain into
sub-acute or chronic categories based on the duration of pain
alone may be of limited value and that this artificial distinction
should be laid to rest. It is not worth trying to draw any inferences
from the apparent differences in treatment response according to
whether the pain has been present for more or less than 90 days.
These results should however be useful for future meta-analyses
and guidelines that may continue to draw a distinction between
acute/subacute and chronic low back pain.
Conclusions
In the main UK BEAM paper, we argued that although the
average effect sizes from our interventions were small to
moderate, some patients were likely to have had larger benefits;
and that because the interventions were very cost-effective these
treatments should be made more generally available. That we have
been unable to identify which patients may get the greatest benefit
from a particular intervention appears to strengthen that position.
In common with previous trials, for example trials of chiro-
practic treatment [38, 39], exercise [40] or physiotherapy [41],
UK BEAM has provided only a partial answer to the question of
how back pain should be treated. The main analyses have shown
incontrovertible evidence of a small to moderate short-term benefit
from all three intervention packages, when added to ‘best care’ in
general practice, along with small sustained benefits from the
manipulation and combined treatment packages. However, the
data have failed to identify which patients will gain the greatest
benefits from which treatment, or which components of the
treatment are responsible for these effects. Since we have
already shown that we can achieve these small to moderate
benefits at a modest cost, it seems reasonable to continue to advise
making these treatments available to patients who are not
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spontaneously improving a few weeks after consulting for an
episode of back pain of any duration.
The authors have declared no conflicts of interest.
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Rheumatology key messages
 Participant baseline characteristics did not identify who was more
likely to respond to physical treatments for low back pain.
 Duration of episode does not predict which patients will get the
greatest benefit from these physical treatments for low back pain.
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